Skip to main content

Find Clinical Trials

Home
Conditions
Schizophrenia

Clinical trial condition

Schizophrenia

Explore clinical trials studying Schizophrenia. Study availability and eligibility vary by location and protocol.

2,318 public trials 177 recruiting studies

Refine in advanced search Browse all conditions

Schizophrenia trial results

Completed

TMS Related Biomarker Assessments

NCT05660018

Conditions: Mental Disorders, Psychotic Disorders, Schizophrenia, +2 more
Locations: University of Maryland, Baltimore Baltimore, Maryland, United States

View Trial Details

Completed

A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia

NCT01626885

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Kurayoshi, Tottori, Japan

View Trial Details

Completed

Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia

NCT00862992

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Hoyu Hospital Kure, Hiroshima, Japan

View Trial Details

Completed

Long-Term Study of MP-214 in Patients With Schizophrenia

NCT01626872

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Sapporo, Hokkaido, Japan

Seoul, South Korea

Taipei, Taiwan

View Trial Details

Completed

A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia

NCT01626859

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Sakai, Osaka, Japan

View Trial Details

Completed

Safety and Efficacy of MP-214 in Patients With Schizophrenia

NCT01625000

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Sapporo, Hokkaido, Japan

Seoul, South Korea

Taipei, Taiwan

View Trial Details

Completed

A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia

NCT01625897

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Aizu-Wakamatsu, Fukushima, Japan

View Trial Details

Completed

Social Cognition in Youth Who Have a First Degree Relative With Schizophrenia

NCT04681807

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: The Royal Ottawa Mental Health Centre Ottawa, Ontario, Canada

View Trial Details

Completed

Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder

NCT06041646

Conditions: Aberrant Motor Behavior in Dementia, Agitation,Psychomotor, Behavior, +18 more
Locations: BioXcel Clinical Research Site Little Rock, Arkansas, United States

BioXcel Clinical Research Site Rogers, Arkansas, United States

View Trial Details

Completed

A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.

NCT04115319

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Research Site Cerritos, California, United States

Research Site Oakland, California, United States

Research Site Oceanside, California, United States

Research Site San Diego, California, United States

View all 42 locations

View Trial Details